Last updated: 11/03/2018 11:33:57
Study to identify and characterize bacteria causing Acute Otitis Media in young children in Turkey
GSK study ID
111339
Clinicaltrials.gov ID
EudraCT ID
Not applicable
EU CT Number
Not applicable
Trial status
Other
Other
Trial overview
Official title: Identification and characterization of the bacteria causing Acute Otitis Media (AOM) episodes in young children in Turkey
Trial description: The purpose of this study is to identify and characterize the bacteria causing complicated Acute Otitis Media episode in children >= 3 months to < 5 years in Turkey.
Primary purpose:
Not applicable
Trial design:
Not applicable
Masking:
Not applicable
Allocation:
Not applicable
Primary outcomes:
Occurrence of bacterial pathogens isolated from middle ear fluid samples.
Timeframe: Not Applicable.
Secondary outcomes:
Occurrence of bacterial serotypes.
Timeframe: Not Applicable.
Antimicrobial susceptibility of bacteria isolated from middle ear fluid samples collected from sub-groups of complicated acute otitis media cases.
Timeframe: Not Applicable.
Occurrence of treatment failure of acute otitis media and of recurrent acute otitis media.
Timeframe: Not Applicable.
Occurrence of bacteria in acute otitis media cases vaccinated with a pneumococcal vaccine.
Timeframe: Not Applicable.
Occurrence of spontaneous otorrhoea.
Timeframe: Not Applicable.
Interventions:
Enrollment:
0
Primary completion date:
Not applicable
Observational study model:
Case-Only
Time perspective:
Prospective
Clinical publications:
Not applicable
- Age: >= 3 months and < 5 years at the time they are seen by the paediatrician. The subject becomes ineligible on the fifth birthday.
- Signs, symptoms, and conditions:
- Hospitalised during the diagnosis of acute otitis media or during treatment.
- Otitis externa, or otitis media with effusion.
Inclusion and exclusion criteria
Inclusion criteria:
- Signs, symptoms, and conditions:
- One of the functional or general signs of otalgia ,conjunctivitis, fever and either
- Paradise’s criteria or
- Spontaneous otorrhoea of less than 24 hours.
- Subjects if classified as recurrent acute otitis media or treatment failure as described below:
- Recurrent acute otitis media: Defined as a subject who has an episode of acute otitis media representing the third new episode within the past 6 months, or the fourth new episode within the past year.
- Treatment failure: Defined as a subject who was diagnosed with acute otitis media and received antibiotic treatment from a physician, but is still symptomatic 48-72 hours after initiation of the treatment. As with other acute otitis media cases, the onset of signs or symptoms should have been within 72 hours prior to the initial visit to the physician.
- Written informed consent obtained from parent or guardian prior to study start.
Age: >= 3 months and < 5 years at the time they are seen by the paediatrician. The subject becomes ineligible on the fifth birthday.
Exclusion criteria:
- Otitis externa, or otitis media with effusion.
- Presence of a transtympanic aerator.
- Systemic antibiotic treatment received for a disease other than acute otitis media in the 72 hours prior to enrolment.
- Receiving antimicrobial prophylaxis for recurrent acute otitis media.
- Provision of antibiotic by paediatrician at the enrolment visit prior to the sampling of the middle ear fluid or spontaneous otorrhoea.
- Patients that are on antibiotics for acute otitis media, and are clinically improving.
Hospitalised during the diagnosis of acute otitis media or during treatment.
Trial location(s)
Study documents
No study documents available.
Results overview
No study documents available
Recruitment status
Other
Actual primary completion date
Not applicable
Actual study completion date
Not applicable
Plain language summaries
Not applicable. GSK’s transparency policy provides for Plain Language Summaries for Interventional studies.
Additional information about the trial
Not applicable
Participate in clinical trial
Access to clinical trial data by researchers
Visit website